SCYNEXIS, Inc.
SCYXNASDAQHealthcare● Active
$4.45
$-0.26(-5.52%)
Market Cap$27984791
P/E Ratio—
52W High$10.48
52W Low$4.45
SCYNEXIS, Inc. (SCYX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SCYX · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 11, 2026EPS Actual
-$3.36
Est. -$0.80 · -320.0%
Revenue
—
Est. $0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 11, 2026
After Market Close
▼ Miss EPS
SCYX reports quarterly as a NASDAQ-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$78.12
Rev. $1025.0B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$78.12
Rev. Est.$1025.0B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | -$0.51 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | May 11, 2026 | -$0.80 | -$3.36 | -320.0% | — | $0.00B | — |
| ▼ Q1 FY2026 | Mar 4, 2026 | $0.29 | $0.25 | -13.8% | $0.02B | $0.01B | +130.2% |
| ▲ Q4 FY2025 | Nov 5, 2025 | -$0.21 | -$0.17 | +19.1% | $0.00B | $0.00B | +150.5% |
| ▲ Q3 FY2025 | Aug 14, 2025 | -$0.23 | -$0.14 | +39.1% | $0.00B | $0.00B | +785.7% |
| ▲ Q2 FY2025 | May 16, 2025 | -$0.23 | -$0.17 | +26.1% | $0.00B | $0.00B | +87.6% |
| ▼ Q1 FY2025 | Mar 12, 2025 | -$0.02 | -$0.09 | -350.0% | $0.00B | $0.01B | -90.4% |
| ▲ Q4 FY2024 | Nov 6, 2024 | -$0.20 | -$0.06 | +70.0% | $0.00B | $0.01B | -89.3% |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
-$0.51
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 11, 2026Miss
EPS Actual
-$3.36
EPS Est.
-$0.80
EPS Surpr.
-320.0%
Revenue
—
Q1 FY2026
Mar 4, 2026Miss
EPS Actual
$0.25
EPS Est.
$0.29
EPS Surpr.
-13.8%
Revenue
$0.02B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
-$0.17
EPS Est.
-$0.21
EPS Surpr.
+19.1%
Revenue
$0.00B
Q3 FY2025
Aug 14, 2025Beat
EPS Actual
-$0.14
EPS Est.
-$0.23
EPS Surpr.
+39.1%
Revenue
$0.00B
Q2 FY2025
May 16, 2025Beat
EPS Actual
-$0.17
EPS Est.
-$0.23
EPS Surpr.
+26.1%
Revenue
$0.00B
Q1 FY2025
Mar 12, 2025Miss
EPS Actual
-$0.09
EPS Est.
-$0.02
EPS Surpr.
-350.0%
Revenue
$0.00B
Q4 FY2024
Nov 6, 2024Beat
EPS Actual
-$0.06
EPS Est.
-$0.20
EPS Surpr.
+70.0%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q3 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q2 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q1 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q4 FY2027 | $-1.12 | $-1.12 | $-1.12 | 1 |
| Q3 FY2027 | $-1.12 | $-1.12 | $-1.12 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 11, 2026 | -320.0% | $7.33 | $6.59 | -10.10% |
| ▼ Q1 FY2026 | Mar 4, 2026 | -13.8% | $6.01 | $6.20 | +3.16% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +19.1% | $5.04 | $5.05 | +0.20% |
| ▲ Q3 FY2025 | Aug 14, 2025 | +39.1% | $6.76 | $6.41 | -5.18% |
| ▲ Q2 FY2025 | May 16, 2025 | +26.1% | $7.83 | $6.32 | -19.28% |
| ▼ Q1 FY2025 | Mar 12, 2025 | -350.0% | $7.21 | $7.30 | +1.25% |
| ▲ Q4 FY2024 | Nov 6, 2024 | +70.0% | $10.64 | $10.56 | -0.75% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -57.9% | $14.88 | $15.28 | +2.69% |
Q2 FY2026-10.10%
Report Date
May 11, 2026
EPS Beat/Miss
-320.0%
Price Before
$7.33
Price After
$6.59
Q1 FY2026+3.16%
Report Date
Mar 4, 2026
EPS Beat/Miss
-13.8%
Price Before
$6.01
Price After
$6.20
Q4 FY2025+0.20%
Report Date
Nov 5, 2025
EPS Beat/Miss
+19.1%
Price Before
$5.04
Price After
$5.05
Q3 FY2025-5.18%
Report Date
Aug 14, 2025
EPS Beat/Miss
+39.1%
Price Before
$6.76
Price After
$6.41
Q2 FY2025-19.28%
Report Date
May 16, 2025
EPS Beat/Miss
+26.1%
Price Before
$7.83
Price After
$6.32
Q1 FY2025+1.25%
Report Date
Mar 12, 2025
EPS Beat/Miss
-350.0%
Price Before
$7.21
Price After
$7.30
Q4 FY2024-0.75%
Report Date
Nov 6, 2024
EPS Beat/Miss
+70.0%
Price Before
$10.64
Price After
$10.56
Q3 FY2024+2.69%
Report Date
Aug 8, 2024
EPS Beat/Miss
-57.9%
Price Before
$14.88
Price After
$15.28
Avg Beat Reaction-6.25%
Avg Miss Reaction-0.75%
Beat Rate4 / 8 quarters
Largest Move-19.28% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SCYX ends December
SCYNEXIS, Inc. (SCYX) most recently reported earnings on May 11, 2026 for Q2 FY2026, posting EPS of $-3.36 — missing the analyst consensus of $-0.80 by -320.0%. The next SCYX earnings date is expected around September 1, 2026.
Each quarter, investors track SCYX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SCYX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SCYX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SCYX earnings · 5 questionsSCYNEXIS, Inc.'s next earnings report is expected around September 1, 2026. SCYX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SCYX historically reports after market close (AMC).
SCYX earnings datewhen is SCYX earningsSCYX next earnings datewhen does SCYX report earningsSCYX earnings calendar
▸ Source: FMP · SCYNEXIS, Inc. SEC filings · US GAAP · SCYNEXIS, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026